| Literature DB >> 29171934 |
Łukasz Janczewski1, Mateusz Psurski2, Marta Świtalska2, Anna Gajda1, Tomasz M Goszczyński2, Józef Oleksyszyn3, Joanna Wietrzyk2, Tadeusz Gajda1.
Abstract
A series of 21 novel, structurally diverse ω-(isothiocyanato)alkylphosphinates and phosphine oxides (ITCs) were designed and synthesized in moderate to good yields. The synthesized compounds were evaluated for in vitro antiproliferative activity using LoVo and LoVo/DX cancer cell lines. The biological activity of the synthesized compounds was higher than that of natural isothiocyanates such as benzyl isothiocyanate or sulforaphane. The antiproliferative activity of selected ITCs was also tested on selected cancer cell lines: A549, MESSA and MESSA/DX-5, HL60 and HL60MX2, BALB/3T3, and 4T1. These compounds were assessed for their mechanism of action as inducers of cell-cycle arrest and apoptosis. Ethyl (6-isothiocyanatohexyl)(phenyl)phosphinate (71) was tested in vivo on the 4T1 cell line and demonstrated moderate antitumor activity, similar to that benzyl isothiocyanate and cyclophosphamide.Entities:
Keywords: apoptosis; cell cycle; isothiocyanates; isothiocyanatoalkyl phosphinates; isothiocyanatoalkyl phosphine oxides
Mesh:
Substances:
Year: 2017 PMID: 29171934 DOI: 10.1002/cmdc.201700619
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466